Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity.

Drugs
V Strand, Jasvinder A Singh

Abstract

Health-related quality of life (HR-QOL) in patients with rheumatoid arthritis (RA) is significantly impaired as a result of pain, deficits in physical function and fatigue associated with this disease. Decrements in HR-QOL are also associated with an increased probability of no longer working, absence from work due to RA-associated sickness, and reduced productivity while at work or in the home, all of which have consequences for the patient as well as society. HR-QOL and productivity are thus important components in the assessment of outcomes in RA, and assessment of HR-QOL is now recommended in clinical trials that assess the efficacy of new treatments for RA. Measures to assess HR-QOL include the Medical Outcomes Study Short Form 36 (SF-36), EuroQol (EQ-5D) and the Health Utilities Index - Mark 3 (HUI3); these measures not only provide an indication of the clinical (i.e. statistical) efficacy of a treatment, but also provide information on whether this efficacy is truly 'meaningful' from a patient's perspective. These measures have been utilized in clinical trials of biological agents in patients with RA, including tumour necrosis factor inhibitors (etanercept, infliximab, adalimumab, certolizumab pegol and golimumab), the c...Continue Reading

References

Mar 1, 1970·Arthritis and Rheumatism·C Ranawat, L R Straub
Jun 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M H BoyleJ Hatcher
Apr 1, 1997·British Journal of Rheumatology·J TalamoA Young
Apr 2, 1998·BMJ : British Medical Journal·G H GuyattR S Goldstein
Nov 17, 1998·Journal of Clinical Epidemiology·J BrazierK Thomas
Apr 5, 2000·PharmacoEconomics·S J CoonsR D Hays
Nov 30, 2000·The New England Journal of Medicine·P E LipskyUNKNOWN Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
Sep 25, 2001·Lancet·D M Lee, M E Weinblatt
Apr 10, 2002·Journal of Health Economics·John BrazierMark Deverill
Nov 26, 2003·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·S Z ZhaoS S Yu
Apr 13, 2004·Arthritis and Rheumatism·R N MainiUNKNOWN Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
Sep 14, 2004·Health Economics·John BrazierJan Busschbach
Sep 30, 2004·Rheumatology·S M M VerstappenUNKNOWN Utrecht Theumatoid Arthritis Cohort Study Group
Apr 20, 2005·PharmacoEconomics·Werner B F BrouwerJohan L Severens
Apr 30, 2005·Annals of the Rheumatic Diseases·S M M VerstappenUNKNOWN Utrecht Rheumatoid Arthritis Cohort Study Group
Nov 1, 2005·Arthritis and Rheumatism·Michael H Weisman
Nov 16, 2005·Occupational Medicine·Wayne BurtonEric Ruderman
Mar 2, 2006·Arthritis and Rheumatism·Josef S SmolenE William St Clair
Oct 3, 2006·Arthritis and Rheumatism·Rafael Ariza-ArizaUNKNOWN Costs and Quality of Life in Rheumatoid Arthritis Study Group
Feb 1, 2007·Arthritis and Rheumatism·Takao Koike, Tatsuya Atsumi

❮ Previous
Next ❯

Citations

Mar 31, 2011·Rheumatology International·Yousra Ibn YacoubNajia Hajjaj-Hassouni
Mar 24, 2010·Zeitschrift für Rheumatologie·W Graninger
Nov 24, 2011·Clinical Rheumatology·Y El MiedanyI Ahmed
Sep 21, 2010·Joint, Bone, Spine : Revue Du Rhumatisme·Aleth PerdrigerLaure Gossec
Mar 14, 2012·Current Opinion in Rheumatology·Minyoung Her, Arthur Kavanaugh
Aug 15, 2013·Inflammatory Bowel Diseases·Anthony BuissonLaurent Peyrin-Biroulet
Oct 15, 2014·Case Reports in Rheumatology·Fabio E OspinaGabriel J Tobón
Mar 6, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Jasvinder A Singh
Jun 26, 2012·Current Opinion in Ophthalmology·Bryant P Carruth, Edward J Wladis
Nov 23, 2011·Reumatología clinica·Gabriel Herrero-BeaumontSantos Castañeda
Dec 6, 2011·Best Practice & Research. Clinical Rheumatology·Bruno FautrelAnnelies Boonen
May 3, 2016·Rheumatic Diseases Clinics of North America·Mary MahieuRosalind Ramsey-Goldman
Sep 14, 2010·Medical Hypotheses·E BrietzkeB Lafer
Jan 26, 2013·Journal of Clinical Epidemiology·Vibeke Strand, Jack E Loftis
Aug 14, 2013·Annals of the Rheumatic Diseases·Polina PutrikUNKNOWN Equity in Clinical Eligibility Criteria for RA treatment Working Group
Oct 2, 2013·Seminars in Arthritis and Rheumatism·Maurizio CutoloPiet L C M van Riel
Jun 25, 2015·Revista da Associação Médica Brasileira·Amanda Figueiredo Barbosa AzevedoEliézer Rushansky
Apr 24, 2018·Expert Review of Clinical Immunology·Tania Gudu, Laure Gossec
Feb 18, 2011·The Cochrane Database of Systematic Reviews·Jasvinder A SinghRachelle Buchbinder
Mar 7, 2018·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Rubén QueiroJavier Ballina
Aug 3, 2011·The Journal of Rheumatology·Rieke AltenUNKNOWN OMERACT RA Flare Definition Working Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.